Brii Biosciences Ltd (2137)

Currency in HKD
1.97
+0.08(+4.23%)
Closed·

2137 Financial Summary

Key Ratios

P/E Ratio-2.19
Price/Book0.42
Debt / Equity1.08%
Return on Equity-18.05%
Dividend Yield0.00%
EBITDA-401.61M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1.03
(-47.69% Downside)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.31 / -0.27
Revenue / Forecast
27.78M / --
EPS Revisions
Last 90 days

FAQ

What were Brii Biosciences's earnings for the latest quarter?

The Brii Biosciences EPS (TTM) is -0.70. Brii Biosciences reported sales of 27.78, net income of -227.63, and EPS of -0.31 for the latest quarter.

What was Brii Biosciences's net income for the latest quarter?

Brii Biosciences's net income for the latest quarter was -227.63.

How did Brii Biosciences's performance compare year-over-year in the latest quarter?

The company's revenue moved from 22.16 in the previous quarter to 27.78 in the latest quarter, and net income moved from -280.54 to -227.63 compared to the previous quarter.

What is Brii Biosciences's net profit margin on a TTM basis?

Brii Biosciences's trailing twelve months (TTM) net profit margin is -1,017.63%.

How does Brii Biosciences's debt to equity ratio compare to industry standards?

Brii Biosciences's total debt-to-equity ratio is 1.08%.

What is Brii Biosciences's return on investment on a TTM basis?

Brii Biosciences's trailing twelve months (TTM) return on investment (ROI) is -18.05%.

Did Brii Biosciences gain or lose cash last quarter?

In the latest quarter, Brii Biosciences's net change in cash was 347.11 million.

What were Brii Biosciences's total assets and liabilities in the latest quarter?

As of the latest quarter, Brii Biosciences reported total assets of 2,706.63 million and total liabilities of 77.42 million.

How has Brii Biosciences's total revenue grown this year?

Brii Biosciences's total revenue was 22.16 in the previous quarter and 27.78 in the latest quarter.

What is Brii Biosciences's gross margin on a TTM basis?

Brii Biosciences's trailing twelve months (TTM) gross margin is 100.00%.

What was Brii Biosciences's revenue per share for the latest quarter?

Brii Biosciences's revenue per share for the latest quarter was 3.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.